Informatie:
Fout:
ID
34559
Beschrijving
An Observational Study of RoActemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Non-Biological DMARDs; ODM derived from: https://clinicaltrials.gov/show/NCT01617005
Link
https://clinicaltrials.gov/show/NCT01617005
Trefwoorden
Versies (1)
- 19-01-19 19-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
19 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Rheumatoid Arthritis NCT01617005
Eligibility Rheumatoid Arthritis NCT01617005
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT01617005
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
adult patients, >18 years of age
boolean
ID.2
Item
moderate to severe active rheumatoid arthritis (eular criteria)
boolean
ID.3
Item
inadequate response to dmards
boolean
ID.4
Item
initiating treatment with roactemra according to summary of product characteristics (spc)
boolean
ID.5
Item
pregnant or lactating females
boolean
ID.6
Item
rheumatic autoimmune disease other than rheumatoid arthritis
boolean
ID.7
Item
prior history or current inflammatory joint disease other than rheumatoid arthritis
boolean
ID.8
Item
previous treatment with any biological drug used in the treatment of rheumatoid arthritis
boolean
ID.9
Item
previous treatment with roactemra/actemra
boolean
ID.10
Item
any contraindication to treatment with roactemra/actemra
boolean